Lung squamous cell carcinoma
Conditions
Interventions
Experimental group:Arterial perfusion
The control group:Intravenous infusion
Sponsors
Chengdu Qingbaijiang District People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 90 Years
Inclusion criteria
Inclusion criteria: 1. All patients were diagnosed with lung squamous cell carcinoma by clinicopathology, and the tumor stage of the patients were all stage III or IV, and the patients were unable or refused surgery, and the patients were unable or refused local radiotherapy; 2. Routine blood and biochemical tests are in line with drug use indicators, and there are no obvious abnormalities in important organs such as the heart, liver, and kidneys; 3. All patients are older than or equal to 18 years old; 4. The survival period of all patients is more than 6 months, and the KPS score is not lower than 70; 5. Non-pregnant and lactating women, subjects who have no pregnancy plan within 6 months after the trial (including male subjects); 6. The patient is conscious and has smooth communication; 7. All patients gave informed consent before participating in the study.
Exclusion criteria
Exclusion criteria: 1. Patients with other malignant tumors (except patients with lung cancer metastasis); 2. Those who have a history of mental illness in the past; 3. Patients who are allergic to immune drugs, chemotherapy drugs and contrast agents; 4. Pregnant or lactating women. 5. The perfusion area has normal tissues and organs that are sensitive to chemotherapy, such as the spinal cord.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Response Evaluation Criteria in solid tumors; | — |
Countries
China
Contacts
Public ContactCao Lei
Chengdu Qingbaijiang District People's Hospital
Outcome results
None listed